Linaprazan and its Impurities

Linaprazan is an experimental drug for the treatment of gastroesophageal reflux disease. Reference standards of Linaprazan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Linaprazan Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 12 2030000

Linaprazan

Linaprazan


  • Catalogue No.:PA 12 2030000

  • CAS :

    248919-64-4

  • Molecular Formula : C21H26N4O2

  • Molecular Weight : 366.47

Drug Reference Standards & Impurity Synthesis in India
PA 12 2031000

5-(2-(8-((2,6-Dimethylbenzyl)amino)-2,3-dimethyl-N-nitrosoimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid

5-(2-(8-((2,6-Dimethylbenzyl)amino)-2,3-dimethyl-N-nitrosoimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid


  • Catalogue No.:PA 12 2031000

  • CAS :

    NA

  • Molecular Formula : C26H31N5O6

  • Molecular Weight : 509.56

Drug Reference Standards & Impurity Synthesis in India
PA 12 2031001

5-(2-(8-((2,6-Dimethylbenzyl)(nitroso)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid

5-(2-(8-((2,6-Dimethylbenzyl)(nitroso)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid


  • Catalogue No.:PA 12 2031001

  • CAS :

    NA

  • Molecular Formula : C26H31N5O6 - 2

  • Molecular Weight : 509.56

pharmaffiliates